P

Inventor

BLIZZARD CHARLES D

US23 patents
⚠️ This page may combine multiple inventors who share the name “BLIZZARD CHARLES D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OCULAR THERAPEUTIX INC

11 patents
US11291627B1Apr 5, 2022

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

OCULAR THERAPEUTIX INC6 citations84
US11534396B2Dec 27, 2022

Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor

OCULAR THERAPEUTIX INC9 citations83
US11439592B2Sep 13, 2022

Ocular implant containing a tyrosine kinase inhibitor

OCULAR THERAPEUTIX INC6 citations83
US11331267B2May 17, 2022

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

OCULAR THERAPEUTIX INC5 citations83
US12357565B2Jul 15, 2025

Ocular implant containing a tyrosine kinase inhibitor

OCULAR THERAPEUTIX INC1 citations72
US12161753B2Dec 10, 2024

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent

OCULAR THERAPEUTIX INC2 citations72
US11779536B2Oct 10, 2023

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

OCULAR THERAPEUTIX INC1 citations72
US11622935B2Apr 11, 2023

Methods of treating ocular diseases using polyalkylene glycol intracameral implants with polyactide travoprost particles

OCULAR THERAPEUTIX INC2 citations70
US12109302B2Oct 8, 2024

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

OCULAR THERAPEUTIX INC0 citations61
US12329853B2Jun 17, 2025

Compositions and methods for treating ocular diseases

OCULAR THERAPEUTIX INC0 citations59
US12453724B2Oct 28, 2025

Ocular implant containing a tyrosine kinase inhibitor

OCULAR THERAPEUTIX INC0 citations53

INCEPT LLC

7 patents

EPIC THERAPEUTICS INC

4 patents

BLIZZARD CHARLES D

1 patent